Life Sciences: Pharmaceuticals & Medical Devices
Secure your supply chain with the industry’s longest-tenured track and trace solutions.
- Raw ingredients to finished goods traceability
- Real-time cold chain monitoring
- Compliance management
- Predictive analytics
Russia 2020: A Guide to Supply Chain Compliance
This guide from rfxcel’s Russian supply chain and compliance specialists provides everything you need to know to be ready for the country’s new regulations in 2020 and beyond.
A Quick Guide to The EU Falsified Medicines Directive
It’s a time of rapid change for the pharmaceutical industry—new procedures, laws, requirements, strategies, and technologies challenge us to engage with our products in the supply chain like never before.
Compliance Checklist: CFR Title 21
The United States Food and Drug Administration (FDA) and the European Commission have defined regulations for the conditions under which regulated companies can submit electronic records in lieu of paper documents.
Latest News & Publications
Securing the Pharma Supply Chain: A Look Back at How We Got Here and Where We’re Going
The push for serialisation and traceability – assigning unique identifiers to individual packs of medications and being able to track them one by one or in larger aggregations – in the pharmaceutical supply chain continues in earnest.
rfxcel to Exhibit, Discuss the Latest DSCSA VRS Developments
October 16, 2019: rfxcel, the global leader in supply chain track and trace solutions and the pharma industry’s thought leader in the Verification Router Service (VRS), will exhibit at the Healthcare Distribution Alliance’s (HDA’s) 2019 Traceability Seminar October 21-23 at the Marriott Wardman Park Hotel in Washington, D.C.
rfxcel Will Demo Its Latest Track and Trace Innovations
October 9, 2019: The team will showcase rfxcel’s latest track and trace innovations, including its signature rfxcel Traceability System (rTS), an improved rfxcel MobileTraceability app, and the rfxcel Integrated Monitoring (rIM) solution.
Real-time Traceability Platform for a Smart Cold Chain
Everything you need to know about the Russian serialization requirements
This webinar will cover the full scope of the serialization requirements in Russia, including all mandatory labeling requirements for 2019 and 2020.
The SNCM – National System for Medicines Control
ANVISA’s mission is “to protect and promote public health and to intervene in the risks caused by the production and use of products regulated by health surveillance.” Access the webinar about upcoming serialization requirements in Brazil.
VRS UPDATE: Hear the Latest Updates on the VRS Effort Here
1. Insight into the Verification Router Service (VRS) 2. Timeline/Updates on the VRS Program 3. rfxcel’s VRS Pilot Findings 4. What’s Next for VRS – Industry Updates
rfxcel MobileTraceability App for Pharma
rfxcel is dedicated to optimizing the pharmaceutical supply chain. We want to remove boundaries, improve data capture and usage, and ensure patient
Full-Stack Track & Trace Solution Benefits Pharma and F&B
The food & beverage (F&B) and pharma industries aren’t quite polar opposites, but they are very different. This includes their
Unpacking the Pharmaceutical Serialization Process
Approaching pharmaceutical serialization is no easy task, but technology makes it infinitely more attainable.
Russia Serialization Deadlines: More Changes for Pharma & Other Industries
The Russian government announced a lot of changes to its serialization timeline, so we’ll keep it simple and list them one by one for pharma and the other product groups, which range from perfume to light industry.
Brazil Track & Trace Requirements & Latest Updates
The SNCM was signed into law by the Brazilian Health Regulatory Agency (ANVISA) on December 28, 2016; it is the first step toward serialization implementation.
What’s Happening with the DSCSA Verification Router Service (VRS)?
Year-End Reflections with Herb Wong, rfxcel’s VP of Marketing & Strategic Initiatives, to get the skinny on what’s going on with the Drug Supply Chain Security Act (DSCSA).